Q2 2018 Conference calls for the media and for analysts
Merck KGaA, Darmstadt, Germany, today reported solid organic sales growth for the second quarter of 2018 and a slight increase in sales despite considerably negative foreign exchange effects.
Type of Event
Conference Call
09 Aug 2018
From 07:00 to 15:00
MERCK KGAA, DARMSTADT, GERMANY, REPORTS SOLID ORGANIC PERFORMANCE IN Q2 2018
- Slight increase in Group sales, slowed down by exchange rate effects
- Life Science and Healthcare drive organic sales growth of 5.2%
- EBITDA pre decreases by –13.7%, impacted primarily by exchange rate effects (–11.0%)
- Merck KGaA, Darmstadt, Germany, confirms forecast for organic development of sales and EBITDA pre
Solid organic sales growth
“In the second quarter, our company generated ."solid organic sales growth, which was mainly attributable to our Life Science and Healthcare business sectors. This also reflects the positive contributions of our new medicines Bavencio and Mavenclad. Performance Materials also generated slight organic sales growth owing to the strong development of Semiconductor Solutions."
(Stefan Oschmann, Chairman of the Executive Board of Merck KGaA, Darmstadt, Germany)
ADDITIONAL INFORMATION & DOWNLOADS
Related News
View All News-
Press Releases
Merck KGaA, Darmstadt, Germany, Reports Solid Organic Performance in Q ...
Merck KGaA, Darmstadt, Germany, today reported solid organic sales growth for the second quarter of 2018 and a slight increase in sales despite considerably negative foreign exchange effects.
2018/08/09